GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Days Sales Outstanding

Adicon Holdings (HKSE:09860) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Days Sales Outstanding?

Adicon Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was HK$2,059 Mil. Adicon Holdings's Revenue for the six months ended in Dec. 2023 was HK$0 Mil.

The historical rank and industry rank for Adicon Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:09860' s Days Sales Outstanding Range Over the Past 10 Years
Min: 121.07   Med: 130.6   Max: 212.41
Current: 173.23

During the past 4 years, Adicon Holdings's highest Days Sales Outstanding was 212.41. The lowest was 121.07. And the median was 130.60.

HKSE:09860's Days Sales Outstanding is ranked worse than
82.27% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs HKSE:09860: 173.23

Adicon Holdings's Days Sales Outstanding declined from Dec. 2022 (154.46) to Dec. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Adicon Holdings Days Sales Outstanding Historical Data

The historical data trend for Adicon Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Days Sales Outstanding Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
131.54 121.07 129.66 212.41

Adicon Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial - 100.20 154.46 227.55 -

Competitive Comparison of Adicon Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Adicon Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adicon Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Adicon Holdings's Days Sales Outstanding falls into.



Adicon Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Adicon Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2282.454 + 1915.899) / 2 ) / 3607.095*365
=2099.1765 / 3607.095*365
=212.41

Adicon Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2201.924 + 1915.899) / 2 ) / 0*365 / 2
=2058.9115 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adicon Holdings  (HKSE:09860) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Adicon Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Adicon Holdings (HKSE:09860) Business Description

Traded in Other Exchanges
Address
No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.
Executives
Cap V General Partner, L.p. 2201 Interest of corporation controlled by you
Cap V, L.l.c. 2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p. 2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c. 2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c. 2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c. 2201 Interest of corporation controlled by you
Pearl Group Limited 2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p. 2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p. 2201 Interest of corporation controlled by you
The Carlyle Group Inc. 2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited 2301 Trustee
Ingenuity Capital Holdings Limited 2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings (HKSE:09860) Headlines

No Headlines